Association of the D repeat polymorphism in the ASPN gene with developmental dysplasia of the hip: A case-control study in Han Chinese

Arthritis Research and Therapy

Volumn 13, Issue 1, 2011, Pages

  Shi, Dongquan ^a,b   Dai, Jin ^a,b   Zhu, Pengsheng ^c   Qin, Jianghui ^a   Zhu, Lunqing ^a   Zhu, Hongtao ^c   Zhao, Baocheng ^c   Qiu, Xusheng ^a   Xu, Zhihong ^a   Chen, Dongyang ^a   Yi, Long ^d   Ikegawa, Shiro ^e   Jiang, Qing ^a,b  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b NANJING UNIVERSITY   (China)

^c Kang'ai Hospital   (China)

^d MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^e RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPORIN; SCLEROPROTEIN; UNCLASSIFIED DRUG; ASPN PROTEIN, HUMAN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CHILD; CHINESE; CONTROLLED STUDY; DEVELOPMENTAL DYSPLASIA OF THE HIP; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENDER; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HIP DYSPLASIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; TANDEM REPEAT; ASIAN; CONGENITAL HIP DISLOCATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; POLYMERASE CHAIN REACTION;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIP DISLOCATION, CONGENITAL; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 79951585162     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3252     Document Type: Article

References (34)

1. Sollazzo V, Bertolani G, Calzolari E, Atti G, Scapoli C. A two-locus model for non-syndromic congenital dysplasia of the hip (CDH). Ann Hum Genet 2000, 64:51-59. 10.1046/j.1469-1809.2000.6410051.x, 11246461.
2. Laurence M, Harper PS, Harris R, Nevin NC, Roberts DF. Report of the delegation of clinical geneticists to China, Spring 1986. Biol Soc 1987, 4:61-77.
3. Hartofilakidis G, Karachalios T, Stamos KG. Epidemiology, demographics, and natural history of congenital hip disease in adults. Orthopedics 2000, 23:823-827.
4. Hasegawa Y, Iwata H, Mizuno M, Genda E, Sato S, Miura T. The natural course of osteoarthritis of the hip due to subluxation or acetabular dysplasia. Arch Orthop Trauma Surg 1992, 111:187-191. 10.1007/BF00571474, 1622705.
5. Russell ME, Shivanna KH, Grosland NM, Pedersen DR. Cartilage contact pressure elevations in dysplastic hips: a chronic overload model. J Orthop Surg Res 2006, 1:6. 10.1186/1749-799X-1-6, 1636031, 17150126.
6. Wilkinson J, Carter C. Congenital dislocation of the hip: the results of conservative treatment. J Bone Joint Surg Br 1960, 42:669-688.
7. Carter C, Wilkinson J. Persistent joint laxity and congenital dislocation of the hip. J Bone Joint Surg Br 1964, 46:40-45.
8. Kramer AA, Berg K, Nance WE. Familial aggregation of congenital dislocation of the hip in a Norwegian population. J Clin Epidemiol 1988, 41:91-96. 10.1016/0895-4356(88)90013-3, 3335875.
9. Czeizel A, Szentpetery J, Tusnady G, Vizkelety T. Two family studies on congenital dislocation of the hip after early orthopaedic screening Hungary. J Med Genet 1975, 12:125-130. 10.1136/jmg.12.2.125, 1013253, 1142376.
10. Geiser M, Buri B, Buri P. Congenital dislocation of the hip in identical twins. J Bone Joint Surg Br 1959, 41:314-318.
11. Mabuchi A, Nakamura S, Takatori Y, Ikegawa S. Familial osteoarthritis of the hip joint associated with acetabular dysplasia maps to chromosome 13q. Am J Hum Genet 2006, 79:163-168. 10.1086/505088, 1474113, 16773577.
12. Dai J, Shi D, Zhu P, Qin J, Ni H, Yao C, Zhu L, Zhao B, Wei J, Liu B, Ikegawa S, Jiang Q, Ding Y. Association of a single nucleotide polymorphism in growth differentiate factor 5 with congenital dysplasia of the hip: a case-control study. Arthritis Res Ther 2008, 10:R126. 10.1186/ar2540, 2592816, 18947434.
13. Rouault K, Scotet V, Autret S, Gaucher F, Dubrana F, Tanguy D, El Rassi CY, Fenoll B, Férec C. Evidence of association between GDF5 polymorphisms and congenital dislocation of the hip in a Caucasian population. Osteoarthritis Cartilage 2010, 18:1144-1149. 10.1016/j.joca.2010.05.018, 20633687.
14. Lorenzo P, Aspberg A, Onnerfjord P, Bayliss MT, Neame PJ, Heinegard D. Identification and characterization of asporin, a novel member of the leucine-rich repeat protein family closely related to decorin and biglycan. J Biol Chem 2001, 276:12201-12211. 10.1074/jbc.M010932200, 11152692.
15. Kizawa H, Kou I, Iida A, Sudo A, Miyamoto Y, Fukuda A, Mabuchi A, Kotani A, Kawakami A, Yamamoto S, Uchida A, Nakamuna K, Notoya K, Nakamura Y, Ikegawa S. An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nat Genet 2005, 37:138-144. 10.1038/ng1496, 15640800.
16. Nakajima M, Kizawa H, Saitoch M, Kou I, Miyazono K, Ikegawa S. Mechanisms for asporin function and regulation in articular cartilage. J Biol Chem 2007, 282:32185-32192. 10.1074/jbc.M700522200, 17827158.
17. Silverio-Ruiz KG, Martinez AE, Garlet GP, Barbosa CF, Silva JS, Cicarelli RM, Valentini SR, Abi-Rached RS, Junior CR. Opposite effects of bFGF and TGF-beta on collagen metabolism by human periodontal ligament fibroblasts. Cytokine 2007, 39:130-137. 10.1016/j.cyto.2007.06.009, 17728137.
18. Okamoto S, Tohyama H, Kondo E, Anaguchi Y, Onodera S, Hayashi K, Yasuda K. Ex vivo supplementation of TGF-beta1 enhances the fibrous tissue regeneration effect of synovium-derived fibroblast transplantation in a tendon defect: a biomechanical study. Knee Surg Sports Traumatol Arthrosc 2008, 16:333-339. 10.1007/s00167-007-0400-2, 17805511.
19. Yamada S, Tomoeda M, Ozawa Y, Yoneda S, Terashima Y, Ikezawa K, Ikegawa S, Saito M, Toyosawa S, Murakami S. PLAP-1/asporin, a novel negative regulator of periodontal ligament mineralization. J Biol Chem 2007, 282:23070-23080. 10.1074/jbc.M611181200, 17522060.
20. Tomoeda M, Yamada S, Shirai H, Ozawa Y, Yanagita M, Murakami S. PLAP-1/asporin inhibits activation of BMP receptor via its leucine-rich repeat motif. Biochem Biophys Res Commun 2008, 371:191-196. 10.1016/j.bbrc.2008.03.158, 18407830.
21. Samee M, Kasugai S, Kondo H, Ohya K, Shimokawa H, Kuroda S. Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J Pharmacol Sci 2008, 108:18-31. 10.1254/jphs.08036FP, 18776714.
22. Lecanda F, Avioli LV, Cheng SL. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem 1997, 67:386-396. 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.0.CO;2-B, 9361193.
23. Jiang Q, Shi D, Yi L, Ikegawa S, Wang Y, Nakamura T, Qiao D, Liu C, Dai J. Replication of the association of the aspartic acid repeat polymorphism in the asporin gene with knee-osteoarthritis susceptibility in Han Chinese. J Hum Genet 2006, 51:1068-1072. 10.1007/s10038-006-0065-6, 17024313.
24. Valdes AM, Loughlin J, Oene MV, Chapman K, Surdulescu GL, Doherty M, Spector TD. Sex and ethnic differences in the association of ASPN, CALM1, COL2A1, COMP, and FRZB with genetic susceptibility to osteoarthritis of the knee. Arthritis Rheum 2007, 56:137-146. 10.1002/art.22301, 17195216.
25. Shi D, Nakamura T, Dai J, Yi L, Qin J, Chen D, Xu Z, Wang Y, Ikegawa S, Jiang Q. Association of the aspartic acid-repeat polymorphism in the asporin gene with age at onset of knee osteoarthritis in Han Chinese population. J Hum Genet 2007, 52:664-667. 10.1007/s10038-007-0166-x, 17603749.
26. Song JH, Lee HS, Kim CJ, Cho YG, Park YG, Nam SW, Lee JY, Park WS. Aspartic acid repeat polymorphism of the asporin gene with susceptibility to osteoarthritis of the knee in a Korean population. Knee 2008, 15:191-195. 10.1016/j.knee.2007.11.005, 18178444.
27. Nakamura T, Shi D, Tzetis M, Rodigiez-Lopex J, Miyamoto Y, Tsezou A, Gonzalez A, Jiang Q, Kamatani N, Loughlin J, Ikegawa S. Meta-analysis of association between the ASPN D-repeat and osteoarthritis. Hum Mol Genet 2007, 16:1676-1681. 10.1093/hmg/ddm115, 17517696.
28. Rodriguez-Lopez J, Pombo-Suarez M, Liz M, Gomez-Reino JJ, Gonzalez A. Lack of association of a variable number of aspartic acid residues in the asporin gene with osteoarthritis susceptibility: case-control studies in Spanish Caucasians. Arthritis Res Ther 2006, 8:R55. 10.1186/ar1920, 1526645, 16542493.
29. Atif U, Philip A, Aponte J, Woldu EM, Brady S, Kraus VB, Jordan JM, Doherty M, Wilson AG, Moskowitz RW, Hochberg M, Loeser R, Renner JB, Chiano M. Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US Caucasians. Osteoarthritis Cartilage 2008, 16:1174-1177. 10.1016/j.joca.2008.03.007, 18434216.
30. Song YQ, Cheung KM, Ho DW, Poon SC, Chiba K, Kawaguchi Y, Hirose Y, Alini M, Grad S, Yee AF, Leong JC, Luk KD, Yip SP, Karppinen J, Cheah KS, Sham P, Ikegawa S, Chan D. Association of the asporin D14 allele with lumbar-disc degeneration in Asians. Am J Hum Genet 2008, 82:744-747. 10.1016/j.ajhg.2007.12.017, 2427233, 18304494.
31. Torres B, Orozco G, García-Lozano JR, Oliver J, Fernández O, González-Gay MA, Balsa A, García A, Pascual-Salcedo D, López-Nevot MA, Núñez-Roldán A, Martín J, González-Escribano MF. Asporin repeat polymorphism in rheumatoid arthritis. Ann Rheum Dis 2007, 66:118-120. 10.1136/ard.2006.055426, 1798423, 16707531.
32. Sherk HH, Pasquariello PS, Watters WC. Congenital dislocation of the hip. A review. Clin Pediatr (Phila) 1981, 20:513-520. 10.1177/000992288102000806, 7018789.
33. Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 1991, 10:506-513.
34. Kou I, Nakajima M, Ikegawa S. Expression and Regulation of the Osteoarthritis-associated Protein Asporin. J Biol Chem 2007, 282:32193-32199. 10.1074/jbc.M706262200, 17804408.